OREIOS international Study

Trial Identifier: D419CR00025
Sponsor: AstraZeneca
NCTID:: NCT05239507
Start Date: February 2022
Primary Completion Date: March 2023
Study Completion Date: March 2023
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil, Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil, 90560030
Brazil, São Paulo São Paulo, Brazil, 1246000
Egypt Alexandira, Egypt
Egypt Assiut, Egypt
Egypt Cairo, Egypt
Egypt Menufia, Egypt
Hong Kong Hong Kong, Hong Kong
India Faridabad, India
India Howrah, India
India Kolkata, India
India New Delhi, India
Kuwait kuwait, Kuwait
Oman Muscat, Oman
Russia Chelyabinsk, Russia
Russia Saint Petersburg, Russia
Saudi Arabia Makkah, Saudi Arabia
Saudi Arabia Riyadh, Saudi Arabia
Singapore Singapore, Singapore
South Korea Seoul, South Korea
United Arab Emirates Abu Dhabi, United Arab Emirates